Tg Therapeutics TGTX
NASDAQ TGTX
$65.76 +1.50 (+2.33%)
At close: Nov 11, 2026 · 4:00 PM EST

Tg Therapeutics (TGTX) Net Long-Term Debt Issued (Repaid) (2010 - 2026)

Updated

Tg Therapeutics (TGTX) posted Non-Current Debt of -$255 million for Q1 2026.

Analysis

Tg Therapeutics (TGTX) Net Long-Term Debt Issued (Repaid) (2010 - 2026) Analysis & Trends

For FY2024, Tg Therapeutics' Non-Current Debt came in at -$107.55 million.

  • In prior years, Tg Therapeutics' Non-Current Debt was -$975,000 in FY2022 and -$30 million in FY2021.
  • The Q1 2026 figure stands as the highest quarterly Non-Current Debt since Q1 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -1.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.91 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -19.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Tg Therapeutics 9.71 Bn 8.96 Bn 217.86 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.00 Bn
Sep 30, 2024 244.82 Mn
Mar 31, 2023 25.00 Mn
Mar 31, 2022 975,000.00
Dec 31, 2021 15.41 Mn
Sep 30, 2021 7.39 Mn
Dec 31, 2019 312,000.00
Sep 30, 2019 -4,000.00
Jun 30, 2019 -61,000.00
Mar 31, 2019 29.74 Mn
Mar 31, 2014 -677,778.00
Jun 30, 2011 -200,000.00
Mar 31, 2011 100,000.00
Sep 30, 2010 -83,333.00
API Access

Tg Therapeutics Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=TGTX&period=max&api_key=YOUR_API_KEY